Drug intelligence / Profile preview

theobromine + caffeine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

**Theobromine + caffeine** is a *combination* of two methylxanthines commonly found together in cocoa and chocolate products but also used experimentally and occasionally in combination dietary supplements. Both are pharmacologically active small molecules with similar core mechanisms: they are **adenosine receptor antagonists** and **phosphodiesterase inhibitors**, resulting in stimulant effects, smooth muscle relaxation (including bronchodilation), and modulated cardiovascular parameters. Theobromine is a more potent cardiac stimulant and vasodilator, but less active than caffeine in the central nervous system and has a longer half-life. Caffeine is a well-characterized CNS stimulant with effects on alertness and blood pressure, while theobromine tends to increase heart rate but not blood pressure, and at higher doses may produce negative mood effects. Their combination is postulated to provide methylxanthine benefits with a somewhat different side effect profile than caffeine alone[1][2][3]. These substances are investigated and used primarily for their psychostimulant, diuretic, and cardiovascular effects.

02

Targets

ADORA2A (Adenosine A₂A Receptor)PDE (Phosphodiesterase family)ADORA1 (Adenosine receptor A1 subtype)

Beyond the preview

Go deeper on theobromine + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on theobromine + caffeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call